======= LATS2 ======= == Gene Information == * **Official Symbol**: LATS2 * **Official Name**: large tumor suppressor kinase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=26524|26524]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NRM7|Q9NRM7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LATS2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LATS2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604861|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. Acts as a tumor suppressor which plays a critical role in centrosome duplication, maintenance of mitotic fidelity and genomic stability. Negatively regulates G1/S transition by down-regulating cyclin E/CDK2 kinase activity. Negative regulator of the androgen receptor. Phosphorylates SNAI1 in the nucleus leading to its nuclear retention and stabilization, which enhances its epithelial-mesenchymal transition and tumor cell invasion/migration activities. This tumor-promoting activity is independent of its effects upon YAP1 or WWTR1/TAZ. {ECO:0000269|PubMed:10871863, ECO:0000269|PubMed:12853976, ECO:0000269|PubMed:15131260, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:21952048}. |Pkinase| |Pkinase C| |Pkinase Tyr| |hippo signaling| |negative regulation of cyclin-dependent protein serine/threonine kinase activity| |negative regulation of cyclin-dependent protein kinase activity| |regulation of organ growth| |regulation of cyclin-dependent protein serine/threonine kinase activity| |regulation of cyclin-dependent protein kinase activity| |G1/S transition of mitotic cell cycle| |cell cycle G1/S phase transition| |spindle pole| |negative regulation of protein serine/threonine kinase activity| |microtubule organizing center| |hormone-mediated signaling pathway| |peptidyl-serine phosphorylation| |negative regulation of canonical Wnt signaling pathway| |peptidyl-serine modification| |negative regulation of Wnt signaling pathway| |negative regulation of protein kinase activity| |negative regulation of kinase activity| |mitotic cell cycle phase transition| |negative regulation of transferase activity| |cell cycle phase transition| |regulation of canonical Wnt signaling pathway| |regulation of developmental growth| |regulation of Wnt signaling pathway| |protein serine/threonine kinase activity| |negative regulation of protein phosphorylation| |negative regulation of phosphorylation| |cell division| |regulation of protein serine/threonine kinase activity| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of cell cycle| |negative regulation of protein modification process| |mitotic cell cycle process| |cellular response to hormone stimulus| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |regulation of growth| |mitotic cell cycle| |positive regulation of cell death| |negative regulation of catalytic activity| |regulation of protein kinase activity| |regulation of kinase activity| |peptidyl-amino acid modification| |response to hormone| |protein phosphorylation| |regulation of transferase activity| |cell cycle process| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |regulation of cell cycle| |cellular response to endogenous stimulus| |negative regulation of signal transduction| |phosphorylation| |cell cycle| |negative regulation of cell communication| |negative regulation of signaling| |regulation of protein phosphorylation| |response to endogenous stimulus| |ATP binding| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of phosphorylation| |negative regulation of response to stimulus| |regulation of cell death| |intracellular signal transduction| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp42|BI-6727 0.001μM R01 exp42]]|-1.87| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6698 * **Expression level (log2 read counts)**: 2.15 {{:chemogenomics:nalm6 dist.png?nolink |}}